It's that time.

Time, time, time.

Lock and load.

The Michael Vary show is on the air.

Sure, we'll get to the news of the day, but first...

Let's look beyond the news of the day.

Because we're not going to discuss what the Washington Post and New York Times want us to discuss.

We're going to talk about what's meaningful, what matters, forest for the trees sort of stuff.

Wal-Mart's chief executive officer said, quote,

we definitely see a change compared to the total population.

We see a pullback in overall basket.

What's he talking about?

Wal-Mart says, ozimpic and the other appetite suppressing drugs are making people by less food.

The company is studying changes in sales patterns using anonymized data on shopper populations.

Sure, it's anonymized. They don't know your name or anything.

Sure, just keep believing that.

It can look at the purchasing changes among people taking the drug and compare those habits to similar people who aren't taking the drug.

Forbes magazine reports, quote,

an increasing number of CEOs and investors are talking about how popular weight loss drugs might change the economy and business.

The CEO of the maker of Pringles and Cheezits said the company is studying their potential impact on dietary behaviors.

Like everything that potentially impacts our business, we'll look at it, study it, and if necessary, mitigate.

Steve Calain, the CEO of Kelanova said in an interview,

...